![Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application | SpringerLink Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00424-020-02433-x/MediaObjects/424_2020_2433_Fig3_HTML.png)
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application | SpringerLink
![JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review | HTML JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review | HTML](https://www.mdpi.com/jcm/jcm-11-01470/article_deploy/html/images/jcm-11-01470-g001.png)
JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review | HTML
![Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience | SpringerLink Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12471-021-01580-9/MediaObjects/12471_2021_1580_Fig1_HTML.png)
Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience | SpringerLink
![IJMS | Free Full-Text | Pleiotropic Effects of Sodium-Glucose Cotransporter- 2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control | HTML IJMS | Free Full-Text | Pleiotropic Effects of Sodium-Glucose Cotransporter- 2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control | HTML](https://www.mdpi.com/ijms/ijms-22-04374/article_deploy/html/images/ijms-22-04374-g002.png)
IJMS | Free Full-Text | Pleiotropic Effects of Sodium-Glucose Cotransporter- 2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control | HTML
![Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective - ScienceDirect Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928098716303141-fx1.jpg)
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective - ScienceDirect
![Sodium–glucose co-transporter 2 (SGLT2) catalyses the active transport... | Download Scientific Diagram Sodium–glucose co-transporter 2 (SGLT2) catalyses the active transport... | Download Scientific Diagram](https://www.researchgate.net/publication/255988083/figure/fig2/AS:203190877331456@1425455888015/Sodium-glucose-co-transporter-2-SGLT2-catalyses-the-active-transport-of-glucose.png)
Sodium–glucose co-transporter 2 (SGLT2) catalyses the active transport... | Download Scientific Diagram
![Sodium–glucose cotransporters: Functional properties and pharmaceutical potential - Sano - 2020 - Journal of Diabetes Investigation - Wiley Online Library Sodium–glucose cotransporters: Functional properties and pharmaceutical potential - Sano - 2020 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/489d3ff0-76e2-494a-86bf-9608098980fc/jdi13255-toc-0001-m.jpg?trick=1659369517910)
Sodium–glucose cotransporters: Functional properties and pharmaceutical potential - Sano - 2020 - Journal of Diabetes Investigation - Wiley Online Library
![PDF] Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents | Semantic Scholar PDF] Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/184e836ab98d09870ce2eb04753cac9a061075cd/4-Figure1-1.png)
PDF] Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents | Semantic Scholar
![Sodium-glucose co-transporter-2 inhibitors: peculiar “hybrid” diuretics that protect from target organ damage and cardiovascular events - Nutrition, Metabolism and Cardiovascular Diseases Sodium-glucose co-transporter-2 inhibitors: peculiar “hybrid” diuretics that protect from target organ damage and cardiovascular events - Nutrition, Metabolism and Cardiovascular Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c11a1168-b566-48dc-9cf1-cebe6d31ba79/gr1_lrg.jpg)
Sodium-glucose co-transporter-2 inhibitors: peculiar “hybrid” diuretics that protect from target organ damage and cardiovascular events - Nutrition, Metabolism and Cardiovascular Diseases
![Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing Pharmacology | Osmosis Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing Pharmacology | Osmosis](https://d16qt3wv6xm098.cloudfront.net/31VVFdUaRe_6mr6mcDEdCOy_S4OtbNQI/_.jpg)
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing Pharmacology | Osmosis
![The potential role and rationale for treatment of heart failure with sodium– glucose co‐transporter 2 inhibitors - Butler - 2017 - European Journal of Heart Failure - Wiley Online Library The potential role and rationale for treatment of heart failure with sodium– glucose co‐transporter 2 inhibitors - Butler - 2017 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/129a352e-afd8-4427-9bdb-7e3da2107aa1/ejhf933-fig-0002-m.jpg)
The potential role and rationale for treatment of heart failure with sodium– glucose co‐transporter 2 inhibitors - Butler - 2017 - European Journal of Heart Failure - Wiley Online Library
![Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review | Journal of the American College of Cardiology Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/1efe0bca-d740-4119-a00a-31714f5748e0/gr6.jpg)
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ... Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...](https://jpet.aspetjournals.org/content/jpet/358/1/94/F1.large.jpg)
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...
Sodium–glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class - MedChemComm (RSC Publishing)
![Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue | Hypertension Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue | Hypertension](https://www.ahajournals.org/cms/asset/95ccbb33-5962-4983-bada-78a6fe9b6ab9/hypertensionaha.120.16466.fig06.jpg)